All In Biotech

Drug Trial Radar · NCT02073279

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Satralizumab (SA237) as Monotherapy in Patients With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Last checked: Nov 20, 2026Latest source record: Mar 1, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

95

Actual

Start

Aug 5, 2014

Primary completion

Oct 12, 2018

Study completion Jan 31, 2022

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
Collaborators
Chugai Pharmaceutical
First posted
Feb 27, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objectives of this study are to evaluate the efficacy, safety, pharmacodynamic, pharmacokinetic and immunogenic profiles of satralizumab in participants with NMO and NMOSD.

Conditions

  • Neuromyelitis Optica (NMO)
  • NMO Spectrum Disorder (NMOSD)

Interventions

  • SatralizumabDrug

    Satralizumab will be administered subcutaneously (SC) at Weeks 0, 2, and 4, and thereafter once every 4 weeks (Q4W).

  • PlaceboDrug

    Placebo will be administered subcutaneously (SC) at Weeks 0, 2, and 4, and thereafter once every 4 weeks (Q4W).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to First Protocol-Defined Relapse (TFR) During the Double-Blind (DB) PeriodTime frame: Up to Week 216

Locations

58 sites in 15 countries. Site status is shown where the registry gives one.

  • University of Colorado Denver -; Neurology

    Aurora, Colorado

  • University of Miami UHealth Professional Arts Center

    Miami, Florida

  • The MS Center of Vero Beach

    Vero Beach, Florida

  • Columbus Research and Wellness

    Columbus, Georgia

  • University of Chicago; Neurology

    Chicago, Illinois

  • Consultants in Neurology Ltd

    Northbrook, Illinois

  • OSF Saint Francis Medical Center

    Peoria, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • MidAmerica Neuroscience Institute

    Prairie Village, Kansas

  • University of Michigan Health System

    Ann Arbor, Michigan

  • Wayne State University - Comp Clinic and MS. Center

    Detroit, Michigan

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • The Neurological Institute PA

    Charlotte, North Carolina

  • OhioHealth Research Institute

    Columbus, Ohio

  • Thomas Jefferson University

    Philadelphia, Pennsylvania

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • Central Texas Neurology Consultants

    Round Rock, Texas

  • UT Medicine San Antonio

    San Antonio, Texas

  • Virginia Commonwealth University

    Richmond, Virginia

  • Wheaton Franciscan Healthcare - St. Francis Outpatient Center; Center for Neurological Disorders

    Milwaukee, Wisconsin

  • Medical Help Center EOOD

    Dobrich, Bulgaria

  • MMA-MHAT Pleven - Clinic for Neurology

    Pleven, Bulgaria

  • UMHAT 'Dr. Georgi Stranski', EAD

    Pleven, Bulgaria

  • MHATNP Sveti Naum EAD

    Sofia, Bulgaria

  • UMHAT Alexandrovska, EAD

    Sofia, Bulgaria

  • MS Clinical Trials Group

    Vancouver, British Columbia, Canada

  • Recherche Sepmus Inc.

    Greenfield Park, Quebec, Canada

  • Centre hospitalier de l'Universite de Montreal (CHUM)

    Montreal, Quebec, Canada

  • Klinicki bolnicki centar Osijek

    Osijek, Croatia

  • LTD Helsicore

    Tbilisi, Georgia

  • Pineo Medical Ecosystem LTD

    Tbilisi, Georgia

  • S.Khechinashvili Tbilisi State Medical University Clinic Ne

    Tbilisi, Georgia

  • PO G.Rodolico, AOU Policlinico-Vittorio Emanuele Catania

    Catania, Sicily, Italy

  • Hospital Kuala Lumpur

    Kuala Lumpur, Malaysia

  • Hospital Universiti Sains Malaysia [Neurology]

    Kubang Kerian, Kelantan, Malaysia

  • Philippine General Hospital

    Manila, Philippines

  • NZOZ Wielospecjalistyczna Poradnia Lekarska SYNAPSIS

    Katowice, Poland

  • Miedzyleski Szpital Specjalistyczny w Warszawie

    Warsaw, Poland

  • San Juan MS Center

    Guaynabo, Puerto Rico

  • SC Clubul Sanatatii SRL

    Campulung Muscel, Romania

Showing 40 of 58 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.